Clinical Trials in Pittsburgh

Showing 12221-12240 of 18,076 trials

Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites

NCT00326885

The purpose of this study is to determine whether the investigational drug catumaxomab is a safe and effective treatment for recurrent symptomatic malignant ascites.

Malignant Ascites

Neovii Biotech32 participantsStarted Jun 2006

Tucson, Arizona, United States • La Jolla, California, United States • Stanford, California, United States +15 more locations

TERMINATEDEARLY Phase 1< 1 mile

Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery

NCT00651976

RATIONALE: Hormone therapy using letrozole may fight breast cancer by lowering the amount of estrogen the body makes. Giving letrozole before surgery allows us to monitor the effects of letrozole on the tumor on a molecular level and determine markers of response to treatment. PURPOSE: This study will show us how well letrozole works in treating postmenopausal women with stage I, II or III breast cancer that can be removed by surgery.

Breast Cancer

Vanderbilt-Ingram Cancer Center213 participantsStarted Mar 2008

Atlanta, Georgia, United States • Tulsa, Oklahoma, United States • Pittsburgh, Pennsylvania, United States +2 more locations

Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites

Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery

Find Trials by Condition in Pittsburgh

Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Safety and Immunogenicity of Different Dosing Schedules of GlaxoSmithkline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine in Adults 50 Years of Age or Older

A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)

Long-term Open-Label Safety Study to Evaluate EN3409

Remission and Flare in Psoriatic Arthritis: a Prospective 6-month Study With a Double Perspective.

An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis

A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza

Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy

Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis

Preference Attributes of ELLIPTA Dry Powder Inhaler (DPI) and HANDIHALER DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Study of Rituximab and Bendamustine With or Without Brentuximab Vedotin for CD30 Positive Diffuse Large B-cell Lymphoma

A Pharmacokinetic/Pharmacodynamic Study of Oseltamivir in Immunocompromised Children With Confirmed Influenza Infection

Markers of Pubertal Suppression During Therapy for Precocious Puberty

Sunitinib Non Small Cell Lung Cancer Patients Over 70

Early Weight-Bearing After Lapidus Arthrodesis

Sym004 in Patients With Advanced Solid Tumors